Skip to main content
Equibles

TD Asset Management Inc

Position in BCYC — Bicycle Therapeutics PLC

CIK 1056053 Toronto, A6
Back to BCYC Full portfolio

Position in BCYC

as of Jun 30, 2026 · filed Aug 4, 2026
Position Value
$390,046
-$36,796 QoQ
Shares Held
91,992
0.0% QoQ
Ownership
0.131%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 103 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BCYC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TD Asset Management Inc holds $1,140,636,067 across 120 Biotechnology names. BCYC ranks #116 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 259,317 $161,694,522
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 207,960 $103,299,970
3 HALO
Halozyme Therapeutics, Inc.
 1,115,730 $87,328,187
4 ALNY
Alnylam Pharmaceuticals, Inc.
 233,696 $70,349,506
5 CYTK
Cytokinetics Inc
 385,130 $32,809,224
6 RPRX
Royalty Pharma plc
 567,497 $31,819,556
7 ASND
Ascendis Pharma A/S
 119,085 $31,762,351
8 KYMR
Kymera Therapeutics, Inc.
 272,900 $31,293,443

All Filings in BCYC

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $390,046 91,992
2026-03-31 $426,842 91,992
2025-12-31 $1,047,783 147,992
2025-09-30 $1,378,432 178,092
2025-06-30 $1,341,989 193,092
2025-03-31 $1,639,351 193,092
2024-12-31 $3,024,224 216,016
2024-09-30 $5,010,644 221,416
2024-06-30 $1,967,044 97,186
2024-03-31 $1,369,151 54,986
2023-12-31 $636,162 35,186
2023-09-30 $1,643,080 81,786
2023-06-30 $601,914 23,586
2023-03-31 $501,674 23,586
2022-12-31 $698,145 23,586
2022-09-30 $362,530 15,586
2022-06-30 $261,533 15,586
2022-03-31 $1,276,293 29,086
2021-12-31 $1,922,639 31,586